Literature DB >> 33360320

Cytotoxicity and DNA interaction in a series of aryl terminated iminopyridine Pt(II) complexes.

Riccardo Bondi1, Lisa Dalla Via2, Mariafrancesca Hyeraci3, Gioele Pagot4, Luca Labella5, Fabio Marchetti1, Simona Samaritani6.   

Abstract

A series of iminopyridine complexes of platinum(II), bearing a flexible diethereal, aryl terminated residue, where the size of aryl group is varied from phenyl to 9-anthracenyl, was synthesized. The new complexes are soluble and stable in DMSO/H2O mixtures. Besides the metal center, aryl groups are available for further interactions with DNA, due to the good side chain flexibility. The new aryl functionalized iminopyridine dichlorido platinum(II) complexes show a significant antiproliferative activity on ovarian carcinoma cells and notably, complex 13 is able to overcome cisplatin resistance. The study of the interaction mode of 13 with DNA highlighted the ability to form a molecular complex characterized by a dual (intercalative and groove binding) geometry. The complex is also able to covalently add to DNA even though interstrand cross-links appear significantly hampered with respect to cisplatin. The interactions with the macromolecule are discussed in view of the observed cell effect.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antiproliferative properties; Cisplatin resistance; DNA interaction; Groove binding; Iminopyridine platinum(II) complexes; Intercalation

Year:  2020        PMID: 33360320     DOI: 10.1016/j.jinorgbio.2020.111335

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  1 in total

1.  trans-Dichloro(triphenylarsino)(N,N-dialkylamino)platinum(II) Complexes: In Search of New Scaffolds to Circumvent Cisplatin Resistance.

Authors:  Mariafrancesca Hyeraci; Laura Agnarelli; Luca Labella; Fabio Marchetti; Maria Luisa Di Paolo; Simona Samaritani; Lisa Dalla Via
Journal:  Molecules       Date:  2022-01-19       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.